Historical Stock Price
ETFs Holding ABBV »    Stock Splits Calendar »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
07/19/2021 $116.67 $117.00 $113.74 $115.42 6.76M
07/20/2021 $115.55 $117.73 $115.46 $116.05 5.58M
07/21/2021 $116.64 $117.07 $115.79 $116.99 4.13M
07/22/2021 $116.64 $117.91 $116.39 $117.54 6.26M
07/23/2021 $117.98 $118.67 $117.57 $118.19 4.41M
AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and Juvederm Collection; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon, Lupron, and Synthroid.
ABBV historical stock prices picture
AbbVie (ABBV) has the following price history information. Looking back at ABBV historical stock prices for the last five trading days, on July 19, 2021, ABBV opened at $116.67, traded as high as $117.00 and as low as $113.74, and closed at $115.42. Trading volume was a total of 6.76M shares. On July 20, 2021, ABBV opened at $115.55, traded as high as $117.73 and as low as $115.46, and closed at $116.05. Trading volume was a total of 5.58M shares. On July 21, 2021, ABBV opened at $116.64, traded as high as $117.07 and as low as $115.79, and closed at $116.99. Trading volume was a total of 4.13M shares. On July 22, 2021, ABBV opened at $116.64, traded as high as $117.91 and as low as $116.39, and closed at $117.54. Trading volume was a total of 6.26M shares. On July 23, 2021, ABBV opened at $117.98, traded as high as $118.67 and as low as $117.57, and closed at $118.19. Trading volume was a total of 4.41M shares.

ABBV Historical Stock Prices By Date:

ABBV historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into AbbVie shares, starting with a $10,000 purchase of ABBV, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 01/02/2013
End date: 07/23/2021
Start price/share: $35.12
End price/share: $118.19
Starting shares: 284.74
Ending shares: 408.01
Dividends reinvested/share: $26.61
Total return: 382.22%
Average Annual Total Return: 20.19%
Starting investment: $10,000.00
Ending investment: $48,235.48
Years: 8.56
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 01/02/2013
End date: 07/23/2021
Start price/share: $35.12
End price/share: $118.19
Dividends collected/share: $26.61
Total return: 312.30%
Average Annual Total Return: 18.01%
Starting investment: $10,000.00
Ending investment: $41,242.90
Years: 8.56
Date Close
07/19/2021$115.42
07/20/2021$116.05
07/21/2021$116.99
07/22/2021$117.54
07/23/2021$118.19
ABBV is categorized under the Healthcare sector; below are some other companies in the same sector:

ABC Historical Stock Prices
ABEO Historical Stock Prices
ABIO Historical Stock Prices
ABMD Historical Stock Prices
ABT Historical Stock Prices
ABV Historical Stock Prices
ACAD Historical Stock Prices
ACER Historical Stock Prices
ACET Historical Stock Prices
ACHC Historical Stock Prices

Also explore: ABBV shares outstanding history

ABBV Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2021, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.